Shares of Tissue Regenix Group plc (LON:TRX – Get Free Report) crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 64.45 ($0.85) and traded as low as GBX 62.62 ($0.82). Tissue Regenix Group shares last traded at GBX 64 ($0.84), with a volume of 5,213 shares traded.
Tissue Regenix Group Stock Performance
The firm has a market capitalization of £45.59 million, a price-to-earnings ratio of -3,131.00 and a beta of 1.59. The business’s fifty day moving average is GBX 65.11 and its 200 day moving average is GBX 64.46. The company has a quick ratio of 2.36, a current ratio of 4.03 and a debt-to-equity ratio of 32.01.
Tissue Regenix Group Company Profile
Tissue Regenix Group plc, a medical technology company, develops and commercializes platform technologies in the field of bone graft substitutes and soft tissue in the United States and internationally. The company operates through dCELL, BioRinse, and GBM-V segments. It also provides dCELL technology, a soft tissue decellularisation process that removes DNA and other cellular material from animal and human soft tissue to repair diseased or damaged body parts; and BioRinse technology, a natural bone filler solution for osteoinductivity to stimulate and regenerate native bone growth.
Read More
- Five stocks we like better than Tissue Regenix Group
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Is Merck Stock Undervalued After Its Colossal Earnings Growth?
- Election Stocks: How Elections Affect the Stock Market
- Top 5 ETFs for Every Investor: From Semiconductors to Defense
- ESG Stocks, What Investors Should Know
- Blade Air Mobility: This Under-the-Radar Stock Could Double Soon
Receive News & Ratings for Tissue Regenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tissue Regenix Group and related companies with MarketBeat.com's FREE daily email newsletter.
